Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McLaughlin

Showing results (711-720 of 726) with videos related to

Pageof 73
Sort By:
The American Journal of Tropical Medicine and Hygiene|May 14, 2020
Snail-Related Contributions from the Schistosomiasis Consortium for Operational Research and Evaluation Program Including Xenomonitoring, Focal Mollusciciding, Biological Control, and ModelingFiona Allan, Shaali M Ame, Yves-Nathan T Tian-Bi, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 8, 2026
Disrupting CDK9 activity suppresses triple-negative breast cancer and is enhanced by EGFR InhibitionVera E van der Noord, Ronan P McLaughlin, Jessica S Karuntu, et al.
Translational Psychiatry|October 20, 2020
Correction: Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP studyAnnamaria Cattaneo, Clarissa Ferrari, Lorinda Turner, et al.
Cancer Discovery|November 17, 2018
PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in CancerVito W Rebecca, Michael C Nicastri, Colin Fennelly, et al.
Elife|February 8, 2021
Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric siteRajendra Uprety, Tao Che, Saheem A Zaidi, et al.
Journal of Medicinal Chemistry|September 10, 2021
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse EffectsSoumen Chakraborty, Jeffrey F DiBerto, Abdelfattah Faouzi, et al.
Neuropharmacology|September 20, 2022
SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic miceJun Zhu, Pamela M Quizon, Yingying Wang, et al.
Journal of Medicinal Chemistry|November 16, 2021
Oxidative Metabolism as a Modulator of Kratom's Biological ActionsSoumen Chakraborty, Rajendra Uprety, Samuel T Slocum, et al.
Translational Psychiatry|July 24, 2020
Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP studyAnnamaria Cattaneo, Clarissa Ferrari, Lorinda Turner, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2016
Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal BleedingJae Y Lee, Stephanie Daignault-Newton, Gerard Heath, et al.
Pageof 73

Showing results (711-720 of 726) with videos related to

Sort By:
Pageof 73
The American Journal of Tropical Medicine and Hygiene|May 14, 2020
Snail-Related Contributions from the Schistosomiasis Consortium for Operational Research and Evaluation Program Including Xenomonitoring, Focal Mollusciciding, Biological Control, and ModelingFiona Allan, Shaali M Ame, Yves-Nathan T Tian-Bi, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 8, 2026
Disrupting CDK9 activity suppresses triple-negative breast cancer and is enhanced by EGFR InhibitionVera E van der Noord, Ronan P McLaughlin, Jessica S Karuntu, et al.
Translational Psychiatry|October 20, 2020
Correction: Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP studyAnnamaria Cattaneo, Clarissa Ferrari, Lorinda Turner, et al.
Cancer Discovery|November 17, 2018
PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in CancerVito W Rebecca, Michael C Nicastri, Colin Fennelly, et al.
Elife|February 8, 2021
Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric siteRajendra Uprety, Tao Che, Saheem A Zaidi, et al.
Journal of Medicinal Chemistry|September 10, 2021
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse EffectsSoumen Chakraborty, Jeffrey F DiBerto, Abdelfattah Faouzi, et al.
Neuropharmacology|September 20, 2022
SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic miceJun Zhu, Pamela M Quizon, Yingying Wang, et al.
Journal of Medicinal Chemistry|November 16, 2021
Oxidative Metabolism as a Modulator of Kratom's Biological ActionsSoumen Chakraborty, Rajendra Uprety, Samuel T Slocum, et al.
Translational Psychiatry|July 24, 2020
Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP studyAnnamaria Cattaneo, Clarissa Ferrari, Lorinda Turner, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2016
Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal BleedingJae Y Lee, Stephanie Daignault-Newton, Gerard Heath, et al.
Pageof 73